Camphor

Camphor

SCHEMBL29673264

CC1(C)C2CC[C@@]1(C)C(=O)C2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 1.00
KMT2A Q03164 4/20 1.00
MEN1 O00255 3/20 1.00
MAPT P10636 2/20 1.00
LMNA P02545 1/20 1.00
L3MBTL1 Q9Y468 1/20 0.52
PTPN1 P18031 1/20 0.41
F2 P00734 2/20 0.41
PRSS1 P07477 2/20 0.41
PRSS2 P07478 2/20 0.41
PRSS3 P35030 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.39
HTT P42858 1/20 0.38
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C19 P33261 1/20 0.38
KDM4E B2RXH2 1/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Camphor SCHEMBL31059217 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA
Camphor SCHEMBL16068 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA
Camphor SCHEMBL1151878 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA
Camphor SCHEMBL1712401 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA
Camphor SCHEMBL16582770 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA
Camphor SCHEMBL13248606 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA
Camphor SCHEMBL15542393 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA
(-)-Camphor SCHEMBL1701376 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA
Camphor SCHEMBL2037672 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA
Camphor SCHEMBL285280 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11345664-B2 Process for the preparation of (S)-Netarsudil,its salts and polymorphs Micro Labs Ltd. (IN) 2022-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11345664-B2 Process for the preparation of (S)-Netarsudil,its salts and polymorphs VKORC1L1, CYP3A4, REN ALDH1A1 1592/4885KMT2A 3775/4885MEN1 2484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.